Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 219,569	$ 128,451
Short-term investments (note 5)	217,220	170,453
Accounts receivable	14,825	2,185
Prepaid expenses and other current assets	19,683	10,741
Total current assets	471,297	311,830
Deferred financing fees	730	650
Long-term investments (note 5)	75,978	0
Long-term prepaid assets	2,240	2,306
Deferred tax asset	1,347	1,218
Property and equipment, net	12,452	11,100
Operating lease right-of-use assets	5,673	5,400
Intangible assets, net	7,492	6,057
Acquired in-process research and development (note 6)	17,628	17,628
Goodwill (note 6)	12,016	12,016
Total assets	606,853	368,205
Current liabilities:
Accounts payable and accrued liabilities (note 7)	36,235	35,691
Fair value of liability classified options (note 12)	34,621	45,569
Current portion of operating lease liability (note 11)	1,895	1,282
Other current liabilities (note 7)	29	10
Total current liabilities	72,780	82,552
Long-term portion of operating lease liability (note 11)	6,591	5,599
Long-term portion of deferred revenue (note 9)	32,941	32,941
Other long-term liabilities (note 7)	2,560	1,024
Deferred tax liability	728	408
Total liabilities	115,600	122,524
Shareholders’ equity:
Common shares, no par value; unlimited authorized shares at June 30, 2020 and December 31, 2019, respectively; 45,563,155 and 39,564,529 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively (note 8b)	708,319	450,210
Additional paid-in capital	150,399	92,839
Accumulated other comprehensive loss	(6,659)	(6,659)
Accumulated deficit	(360,806)	(290,709)
Total shareholders’ equity	491,253	245,681
Total liabilities and shareholders’ equity	606,853	368,205
Commitments and contingencies (note 13)